EXPLORE!

Survey in England finds high antibody levels with Pfizer vaccine

  636 Views

eMediNexus    25 February 2021

People in England who have been administered two doses of the Pfizer-BioNTech COVID-19 vaccine have developed strong antibody responses, suggests a new survey.

The survey conducted by the Imperial College London revealed that 87.9% of the individuals above 80 years of age tested positive for antibodies following two doses of the Pfizer vaccine. The figure stands at 95.5% among those below 60 years of age and 100% for those below 30. Close to 95% of the individuals below 30 years of age tested positive for antibodies 21 days after one dose, though the figure declined in older age groups. This home surveillance study for COVID-19 antibodies included more than 154,000 participants… (Reuters, February 25, 2021)

To comment on this article,
create a free account.

Sign Up to instantly get access to 10000+ Articles & 1000+ Cases

Already registered?

Login Now

Most Popular Articles

News and Updates

eMediNexus provides latest updates on medical news, medical case studies from India. In-depth medical case studies and research designed for doctors and healthcare professionals.